Healthcare -
Biotechnology - NASDAQ - US
$ 596.85
-1.65 %
$ 63.4 B
Market Cap
15.38
P/E
REGN - LONG-TERM DEBT
Long-term Debt REGN - Regeneron Pharmaceuticals, Inc.
1.98 B
LAST VALUE
-14.29%
2 YEAR CAGR
22.69%
5 YEAR CAGR
15.80%
10 YEAR CAGR